This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Czerkinsky, C Articles by Holmgren, J Search for Related Content PubMed PubMed Citation Articles by Czerkinsky, C Articles by Holmgren, J

 Previous Article  |  Next Article 

Infect Immun. 1991 March; 59(3): 996-1001

Antibody-producing cells in peripheral blood and salivary glands after oral cholera vaccination of humans.

Department of Medical Microbiology and Immunology, University of Göteborg, Sweden.

ABSTRACT

We examined whether immunization with a newly developed oral cholera vaccine would elicit gut-derived antibody-producing cells in the blood and in distant mucosal tissues, such as the minor salivary glands, in 30 adult Swedish volunteers. The results of this study demonstrated that this vaccine indeed induced production of specific antibody-producing cells against the cholera toxin B subunit in both peripheral blood and salivary glands. The response in blood, which after primary and booster immunizations comprised both immunoglobulin A (IgA) and IgG antibody-forming cells, was highly transient and preceded the response in salivary glands; the latter response was restricted to the IgA isotype. The results provide further evidence of the existence of a common mucosal immune system in humans. Furthermore, these findings support previous observations that in animals, the cholera toxin B subunit may be a useful carrier protein for preparing enteric vaccines against pathogens encountered at intestinal and extraintestinal mucosal sites.

This article has been cited by other articles:

• Trollmo, C., Gudmundsson, S., Feltelius, N., Rogberg, S., Smedegard, G., Klareskog, L. (2007). Sulphasalazine inhibits human antigen-specific immune responses in vivo. Ann Rheum Dis 66: 481-485 [Abstract] [Full Text]  
• Banerjee, S, Medina-Fatimi, A, Nichols, R, Tendler, D, Michetti, M, Simon, J, Kelly, C P, Monath, T P, Michetti, P (2002). Safety and efficacy of low dose Escherichia coli enterotoxin adjuvant for urease based oral immunisation against Helicobacter pylori in healthy volunteers. Gut 51: 634-640 [Abstract] [Full Text]  
• Lundin, B. S., Johansson, C., Svennerholm, A.-M. (2002). Oral Immunization with a Salmonella enterica Serovar Typhi Vaccine Induces Specific Circulating Mucosa-Homing CD4+ and CD8+ T Cells in Humans. Infect. Immun. 70: 5622-5627 [Abstract] [Full Text]  
• George-Chandy, A., Eriksson, K., Lebens, M., Nordstrom, I., Schon, E., Holmgren, J. (2001). Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells. Infect. Immun. 69: 5716-5725 [Abstract] [Full Text]  
• Jertborn, M., Nordstrom, I., Kilander, A., Czerkinsky, C., Holmgren, J. (2001). Local and Systemic Immune Responses to Rectal Administration of Recombinant Cholera Toxin B Subunit in Humans. Infect. Immun. 69: 4125-4128 [Abstract] [Full Text]  
• Marcotte, H., Lavoie, M. C. (1998). Oral Microbial Ecology and the Role of Salivary Immunoglobulin A. Microbiol. Mol. Biol. Rev. 62: 71-109 [Abstract] [Full Text]  
• Johansson, E.-L., Rask, C., Fredriksson, M., Eriksson, K., Czerkinsky, C., Holmgren, J. (1998). Antibodies and Antibody-Secreting Cells in the Female Genital Tract after Vaginal or Intranasal Immunization with Cholera Toxin B Subunit or Conjugates. Infect. Immun. 66: 514-520 [Abstract] [Full Text]